智力或发育障碍人士的乳腺癌(女性)、结直肠癌和肺癌存活率:基于人群的回顾性队列研究。

IF 2.9 4区 医学 Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Canadian Journal of Public Health-Revue Canadienne De Sante Publique Pub Date : 2024-04-01 Epub Date: 2024-02-05 DOI:10.17269/s41997-023-00844-8
Rebecca L Hansford, Hélène Ouellette-Kuntz, Rebecca Griffiths, Julie Hallet, Kathleen Decker, David E Dawe, Mark Kristjanson, Virginie Cobigo, Shahin Shooshtari, Morgan Stirling, Christine Kelly, Marni Brownell, Donna Turner, Alyson Mahar
{"title":"智力或发育障碍人士的乳腺癌(女性)、结直肠癌和肺癌存活率:基于人群的回顾性队列研究。","authors":"Rebecca L Hansford, Hélène Ouellette-Kuntz, Rebecca Griffiths, Julie Hallet, Kathleen Decker, David E Dawe, Mark Kristjanson, Virginie Cobigo, Shahin Shooshtari, Morgan Stirling, Christine Kelly, Marni Brownell, Donna Turner, Alyson Mahar","doi":"10.17269/s41997-023-00844-8","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Cancer is a leading cause of death among people living with intellectual or developmental disabilities (IDD). There is little empirical evidence documenting survival or comparing outcomes to those without IDD. This study investigated the association between IDD and cancer survival among adults with breast (female), colorectal, or lung cancer.</p><p><strong>Methods: </strong>A population-based retrospective cohort study was conducted in Ontario, Canada, with routinely collected data. Patients with breast, colorectal, or lung cancer were included (2007‒2019). IDD status before cancer was determined using an established administrative data algorithm. The outcomes of interest included death from any cause and death from cancer. Cox proportional hazards models and competing events analyses using multivariable cause-specific hazards regression were completed. Analyses were stratified by cancer type. Interactions with age, sex, and stage at diagnosis, as well as sensitivity analyses, were completed.</p><p><strong>Results: </strong>The final cohorts included 123,695 breast, 98,809 colorectal, and 116,232 lung cancer patients. Individuals with IDD experienced significantly worse survival than those without IDD. The adjusted hazard ratios of all-cause death were 2.74 (95% CI 2.41‒3.12), 2.42 (95% CI 2.18‒2.68), and 1.49 (95% CI 1.34‒1.66) times higher for breast, colorectal, and lung cancer patients with IDD relative to those without. These findings were consistent for cancer-specific deaths. With few exceptions, worse survival for people with IDD persisted regardless of stage at diagnosis.</p><p><strong>Conclusion: </strong>People with IDD experienced worse cancer survival than those without IDD. Identifying and intervening on the factors and structures responsible for survival disparities is imperative.</p>","PeriodicalId":51407,"journal":{"name":"Canadian Journal of Public Health-Revue Canadienne De Sante Publique","volume":null,"pages":null},"PeriodicalIF":2.9000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11027730/pdf/","citationCount":"0","resultStr":"{\"title\":\"Breast (female), colorectal, and lung cancer survival in people with intellectual or developmental disabilities: A population-based retrospective cohort study.\",\"authors\":\"Rebecca L Hansford, Hélène Ouellette-Kuntz, Rebecca Griffiths, Julie Hallet, Kathleen Decker, David E Dawe, Mark Kristjanson, Virginie Cobigo, Shahin Shooshtari, Morgan Stirling, Christine Kelly, Marni Brownell, Donna Turner, Alyson Mahar\",\"doi\":\"10.17269/s41997-023-00844-8\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>Cancer is a leading cause of death among people living with intellectual or developmental disabilities (IDD). There is little empirical evidence documenting survival or comparing outcomes to those without IDD. This study investigated the association between IDD and cancer survival among adults with breast (female), colorectal, or lung cancer.</p><p><strong>Methods: </strong>A population-based retrospective cohort study was conducted in Ontario, Canada, with routinely collected data. Patients with breast, colorectal, or lung cancer were included (2007‒2019). IDD status before cancer was determined using an established administrative data algorithm. The outcomes of interest included death from any cause and death from cancer. Cox proportional hazards models and competing events analyses using multivariable cause-specific hazards regression were completed. Analyses were stratified by cancer type. Interactions with age, sex, and stage at diagnosis, as well as sensitivity analyses, were completed.</p><p><strong>Results: </strong>The final cohorts included 123,695 breast, 98,809 colorectal, and 116,232 lung cancer patients. Individuals with IDD experienced significantly worse survival than those without IDD. The adjusted hazard ratios of all-cause death were 2.74 (95% CI 2.41‒3.12), 2.42 (95% CI 2.18‒2.68), and 1.49 (95% CI 1.34‒1.66) times higher for breast, colorectal, and lung cancer patients with IDD relative to those without. These findings were consistent for cancer-specific deaths. With few exceptions, worse survival for people with IDD persisted regardless of stage at diagnosis.</p><p><strong>Conclusion: </strong>People with IDD experienced worse cancer survival than those without IDD. Identifying and intervening on the factors and structures responsible for survival disparities is imperative.</p>\",\"PeriodicalId\":51407,\"journal\":{\"name\":\"Canadian Journal of Public Health-Revue Canadienne De Sante Publique\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.9000,\"publicationDate\":\"2024-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11027730/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Canadian Journal of Public Health-Revue Canadienne De Sante Publique\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.17269/s41997-023-00844-8\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/2/5 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Canadian Journal of Public Health-Revue Canadienne De Sante Publique","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.17269/s41997-023-00844-8","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/2/5 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0

摘要

目标:癌症是智力或发育障碍(IDD)患者的主要死因。目前几乎没有实证证据可以证明其存活率或与非 IDD 患者的结果进行比较。本研究调查了患有乳腺癌(女性)、结肠直肠癌或肺癌的成年人中 IDD 与癌症存活率之间的关系:方法:在加拿大安大略省进行了一项基于人群的回顾性队列研究,研究使用了常规收集的数据。研究纳入了乳腺癌、结肠直肠癌或肺癌患者(2007-2019 年)。癌症前的 IDD 状态是通过既定的行政数据算法确定的。相关结果包括任何原因导致的死亡和癌症导致的死亡。利用多变量病因特异性危险回归完成了 Cox 比例危险模型和竞争事件分析。分析按癌症类型进行分层。还完成了与年龄、性别和诊断分期的交互作用以及敏感性分析:最终的队列包括 123,695 名乳腺癌患者、98,809 名结直肠癌患者和 116,232 名肺癌患者。IDD患者的生存率明显低于非IDD患者。患有 IDD 的乳腺癌、结直肠癌和肺癌患者的全因死亡调整危险比分别为 2.74(95% CI 2.41-3.12)、2.42(95% CI 2.18-2.68)和 1.49(95% CI 1.34-1.66)倍。这些发现与癌症特异性死亡的情况一致。除少数例外情况外,无论诊断时处于哪个阶段,IDD患者的生存率都较低:结论:IDD患者的癌症生存率低于非IDD患者。当务之急是找出并干预造成生存率差异的因素和结构。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Breast (female), colorectal, and lung cancer survival in people with intellectual or developmental disabilities: A population-based retrospective cohort study.

Objectives: Cancer is a leading cause of death among people living with intellectual or developmental disabilities (IDD). There is little empirical evidence documenting survival or comparing outcomes to those without IDD. This study investigated the association between IDD and cancer survival among adults with breast (female), colorectal, or lung cancer.

Methods: A population-based retrospective cohort study was conducted in Ontario, Canada, with routinely collected data. Patients with breast, colorectal, or lung cancer were included (2007‒2019). IDD status before cancer was determined using an established administrative data algorithm. The outcomes of interest included death from any cause and death from cancer. Cox proportional hazards models and competing events analyses using multivariable cause-specific hazards regression were completed. Analyses were stratified by cancer type. Interactions with age, sex, and stage at diagnosis, as well as sensitivity analyses, were completed.

Results: The final cohorts included 123,695 breast, 98,809 colorectal, and 116,232 lung cancer patients. Individuals with IDD experienced significantly worse survival than those without IDD. The adjusted hazard ratios of all-cause death were 2.74 (95% CI 2.41‒3.12), 2.42 (95% CI 2.18‒2.68), and 1.49 (95% CI 1.34‒1.66) times higher for breast, colorectal, and lung cancer patients with IDD relative to those without. These findings were consistent for cancer-specific deaths. With few exceptions, worse survival for people with IDD persisted regardless of stage at diagnosis.

Conclusion: People with IDD experienced worse cancer survival than those without IDD. Identifying and intervening on the factors and structures responsible for survival disparities is imperative.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Canadian Journal of Public Health-Revue Canadienne De Sante Publique
Canadian Journal of Public Health-Revue Canadienne De Sante Publique PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH-
CiteScore
6.10
自引率
4.70%
发文量
128
期刊介绍: The Canadian Journal of Public Health is dedicated to fostering excellence in public health research, scholarship, policy and practice. The aim of the Journal is to advance public health research and practice in Canada and around the world, thus contributing to the improvement of the health of populations and the reduction of health inequalities. CJPH publishes original research and scholarly articles submitted in either English or French that are relevant to population and public health. CJPH is an independent, peer-reviewed journal owned by the Canadian Public Health Association and published by Springer.   Énoncé de mission La Revue canadienne de santé publique se consacre à promouvoir l’excellence dans la recherche, les travaux d’érudition, les politiques et les pratiques de santé publique. Son but est de faire progresser la recherche et les pratiques de santé publique au Canada et dans le monde, contribuant ainsi à l’amélioration de la santé des populations et à la réduction des inégalités de santé. La RCSP publie des articles savants et des travaux inédits, soumis en anglais ou en français, qui sont d’intérêt pour la santé publique et des populations. La RCSP est une revue indépendante avec comité de lecture, propriété de l’Association canadienne de santé publique et publiée par Springer.
期刊最新文献
Factors associated with the development, severity, and resolution of post COVID-19 condition in adults living in Canada, January 2020 to August 2022. Unmasking population undercounts, health inequities, and health service access barriers across Indigenous populations in urban Ontario. Action needed to address molecular HIV surveillance ethical concerns. Routine vaccination coverage at ages 2 and 7, before, during, and after the COVID-19 pandemic: Results from the STARVAX surveillance system. To use or not to use behavioural science evidence in designing health promotion interventions: Identification of targets for capacity building.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1